WELL Health Technologies (TSE:WELL - Get Free Report) had its price objective lifted by analysts at Raymond James from C$10.00 to C$11.00 in a note issued to investors on Tuesday,BayStreet.CA reports. Raymond James' target price would indicate a potential upside of 55.15% from the stock's current price.
WELL has been the topic of a number of other research reports. CIBC raised their target price on shares of WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday. Scotiabank lifted their price objective on WELL Health Technologies from C$6.00 to C$7.00 in a research report on Monday. TD Securities increased their target price on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday. Haywood Securities lifted their price target on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday. Finally, Ventum Financial cut their price objective on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating on the stock in a report on Tuesday, October 29th.
Check Out Our Latest Stock Report on WELL Health Technologies
WELL Health Technologies Price Performance
Shares of TSE WELL traded up C$0.10 during trading on Tuesday, reaching C$7.09. The company had a trading volume of 2,137,436 shares, compared to its average volume of 893,325. The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57. The stock has a market capitalization of C$1.77 billion, a PE ratio of 12.44, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a twelve month low of C$3.41 and a twelve month high of C$7.17. The stock has a 50-day moving average price of C$5.24 and a two-hundred day moving average price of C$4.73.
About WELL Health Technologies
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Read More
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
